KCLI (Kansas City Life Insurance Co) Research & Development: $0.0 Mil (TTM As of Mar. 2026)


KCLI Kansas City Life Insurance Co KCLI
66 GF Score
Price $33.42
GF Value $37.08
Valuation Modestly Undervalued
View Full Analysis

What is Kansas City Life Insurance Co Research & Development?

Kansas City Life Insurance Co KCLI 66 Research & Development is $0.0 Mil as of Mar. 2026. GuruFocus rates KCLI with a GF Score™ of 66/100 and a GF Value™ of $37.08 (Modestly Undervalued).

Research & Development is the aggregate amount of research and development expenses during the year. Kansas City Life Insurance Co's Research & Development for the three months ended in Mar. 2026 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0.0 Mil.

Kansas City Life Insurance Co  (OTCPK:KCLI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Kansas City Life Insurance Co Research & Development Related Terms

Kansas City Life Insurance Co Research & Development Historical Data

* Premium members only.

The historical data trend for Kansas City Life Insurance Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kansas City Life Insurance Co Research & Development Chart

Kansas City Life Insurance Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Kansas City Life Insurance Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
KCLI
66GF Score
Kansas City Life Insurance Co KCLI
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kansas City Life Insurance Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.0 Mil mean?
Kansas City Life Insurance Co (KCLI) has a Research & Development of $0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Kansas City Life Insurance Co and its competitors.
Is Kansas City Life Insurance Co's Research & Development too high?
Kansas City Life Insurance Co's current Research & Development is $0.0 Mil. Overall, Kansas City Life Insurance Co has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kansas City Life Insurance Co's Research & Development compare to CIA and SNFCA?
Kansas City Life Insurance Co's Research & Development of $0.0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Kansas City Life Insurance Co and its competitors. Kansas City Life Insurance Co's current Research & Development is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kansas City Life Insurance Co stock overvalued right now?
Based on GuruFocus' analysis, Kansas City Life Insurance Co (KCLI) is currently considered Modestly Undervalued. The stock's GF Value™ is $37.08, compared to a current price of $33.42 — trading 9.9% below its estimated fair value. The current Research & Development is $0.0 Mil. Kansas City Life Insurance Co's overall GF Score™ is 66/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Kansas City Life Insurance Co (KCLI), the current Research & Development is $0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kansas City Life Insurance Co (KCLI) Overvalued in 2026?

Based on GuruFocus' analysis, Kansas City Life Insurance Co stock appears to be undervalued. The current stock price of $33.42 is trading 9.9% below its estimated GF Value™ of $37.08. GuruFocus considers Kansas City Life Insurance Co to be Modestly Undervalued.

Key valuation signals for KCLI:

  • Research & Development: $0.0 Mil
  • GF Value™: $37.08 vs. price of $33.42 (9.9% below fair value)
  • GF Score™: 66/100

No single metric tells the full story. See the KCLI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kansas City Life Insurance Co Business Description

Address 3520 Broadway, Kansas, MO, USA, 64111-2565
Kansas City Life Insurance Co is a Missouri-domiciled insurance company providing individual life, annuity, and group products through general agencies located throughout the United States. The company operates its business in three segments; The Individual Insurance segment consists of individual insurance products for Kansas City Life, Grange Life, and the assumed reinsurance transactions; The Group Insurance segment consists of sales of group life, dental, vision, disability, accident, and critical illness products; and The Old American segment consists of individual insurance products designed largely as final expense products. The company makes the majority of its revenue from the Individual Insurance Segment.
66GF Score

Get the complete analysis for KCLI

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$33.42
Price
$37.08
GF Value